Global Hemostatic Wound Dressing Market, By Type (Thrombin based Hemostats, Gelatin Hemostats, Combination Hemostats, Collagen based Hemostats, Oxidized Regenerated Cellulose Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery), End-User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, Austria, Hungary, Poland, Ireland, Lithuania, Norway, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Kuwait and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.
Hemostatic Wound Dressing Market Analysis and Size
Hemostatic wound dressing as one of the important medical products. Different countries have put forward certain requirements on the qualification certification, production and management of hemostatic dressing, resulting in certain barriers to entry into the industry.
Data Bridge Market Research analyses that the Hemostatic Wound Dressing market which was USD 415.00 million in 2022, would rocket up to USD 740.00 million by 2030, and is expected to undergo a CAGR of 10.15% during the forecast period. This indicates the market value. Thrombin based Hemostats dominate the type segment of the Hemostatic Wound Dressing market owing to the growing demand for inflammation testing. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Hemostatic Wound Dressing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
By Type (Thrombin based Hemostats, Gelatin Hemostats, Combination Hemostats, Collagen based Hemostats, Oxidized Regenerated Cellulose Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery), End-User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Baxter (U.S), Stryker (U.S),, CryoLife (U.S),, BD (U.S), Pfizer Inc. (U.S), Medtronic (Ireland), Axio Biosolutions Pvt Ltd (India), Aesculap, Inc. (U.S), ARGON MEDICAL (U.S), Tricol Biomedical (U.S), Integra LifeSciences Corporation(U.S) among others
|
|
Market Opportunities
|
|
Market Definition
Hemostatic dressings have the ability to promote blood clotting. Hemostatic dressings stop bleeding from abrasions, puncture wounds, or bleeding from veins or arteries. Hemostatic dressings are used in wound management in a variety of situations, including surgery, emergency and trauma, military gunshot wounds, and more.
Global Hemostatic Wound Dressing Market Dynamics
Drivers
- Research and development proficiencies
Rising expenditure for research and development proficiencies, especially in the developed and developing economies pertaining to medical drugs, will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments is also expected to drive the market growth rate.
- Increasing Prevalence of Diseases
The rising prevalence of diseases worldwide is a significant driver for the treatment market. Chronic diseases such as rheumatoid arthritis, multiple sclerosis, lupus, Hemostatic Wound Dressing and psoriasis affect millions of people globally. This growing patient population fuels the demand for effective treatment options.
- Advancements in Diagnostic Technologies
Advances in diagnostic technologies have improved the early detection and diagnosis of diseases. The development of more accurate and reliable diagnostic tools enables healthcare providers to identify diseases at an earlier stage, leading to prompt treatment initiation and better patient outcomes.
Opportunities
Furthermore, an upsurge in the public-private funding for target research activities, rising demand for chronic diseases treatments and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the rising internet penetration rate, rise in the elderly and obese population globally, and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, high costs associated with research and development proficiencies, limited infrastructural facilities, high costs associated with sports medicine, and a dearth of awareness in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This Hemostatic Wound Dressing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Hemostatic Wound Dressing market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In June 2023, BD launched Arista AH, which is a plant based absorbable surgical hemostatic powder derived from purified plant starch. The company stated this will acts as an adjunctive hemostatic device to assist when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures are ineffective or impractical.
Global Hemostatic Wound Dressing market Scope
The Hemostatic Wound Dressing market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Thrombin based Hemostats
- Gelatin Hemostats
- Combination Hemostats
- Collagen based Hemostats
- Oxidized Regenerated Cellulose Hemostats
Application
- Trauma
- Cardiovascular Surgery
- General Surgery
- Plastic Surgery
- Orthopedic Surgery
- Neurosurgery
End User
- Hospitals
- Ambulatory Surgical Centers
- Tactical Combat Casualty Care Centers
Global Hemostatic Wound Dressing Market Regional Analysis/Insights
The global Hemostatic Wound Dressing market is analysed and market size insights and trends are provided by country, type, application and end user, as referenced above.
The countries covered in the Hemostatic Wound Dressing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the Hemostatic Wound Dressing market because of the strong base of testing facilities, the strong presence of major players in the market and the rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, a large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Hemostatic Wound Dressing market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Hemostatic Wound Dressing market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Hemostatic Wound Dressing market. The data is available for the historic period 2010-2020.
Competitive Landscape and Hemostatic Wound Dressing Market Share Analysis
The Hemostatic Wound Dressing market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the Hemostatic Wound Dressing market.
Some of the major players operating in the global hemostatic Wound Dressing market are:
- Baxter (U.S)
- Stryker (U.S)
- CryoLife (U.S)
- BD (U.S)
- Pfizer Inc. (U.S)
- Medtronic (Ireland)
- Axio Biosolutions Pvt Ltd (India)
- Aesculap, Inc. (U.S)
- ARGON MEDICAL (U.S)
- Tricol Biomedical (U.S)
- Integra LifeSciences Corporation(U.S)
SKU-